Assessment of Quality of Life of Hepatitis C Patients Treated By Sovaldi Drug in Viral Hepatitis Treatment Center in Ismailia Fever Hospital, Egypt

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Liver

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2167-0889.1000233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of Anemia among Community Dwelling Elderly in Dakahlia as a Representative of Rural Areas in Egypt and Its Impact on Their Functional Status

  2015cited by this paper
• Sofosbuvir (Sovaldi) for the treatment of hepatitis C

  2014cited by this paper
• Egypt Demographic and Health Survey 2000.

  2009cited by this paper
• Liver stem cells: A scientific and clinical perspective

  2008cited by this paper
• Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors.

  2005cited by this paper
• The impact of diagnosis of hepatitis C virus on quality of life

  1999cited by this paper
• Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

  1999cited by this paper
• Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients.

  1999cited by this paper
• Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

  1998cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• Assessment of quality-of-life outcomes.

  1996cited by this paper

• Correlation between the patients with Hepatitis C Virus and their Health-Related Quality of Life

  2020cites this paper
• Effect of Health Education Program on Life Style of Patients with Hepatitis C Virus Receiving Sovaldi Combination Therapy

  year unknowncites this paper